Kiniksa Pharmaceuticals International, plc Contract Liability (Deferred Revenue)
Kiniksa Pharmaceuticals International, plc (KNSA) had Contract Liability (Deferred Revenue) of $12.00 thousand as of 2024-06-30, per its 10-Q filed 2024-07-25.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2025-02-25
- 2024-06-30: Contract with Customer, Liability, Current $12.00K.
- 2024-03-31: Contract with Customer, Liability, Current $156.00K.
- 2023-12-31: Contract with Customer, Liability, Current $307.00K.
- 2023-09-30: Contract with Customer, Liability, Current $2.56M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2024-06-30 | $12.00K 10-Q · filed 2024-07-25 |
| 2024-03-31 | $156.00K 10-Q · filed 2024-04-25 |
| 2023-12-31 | $307.00K 10-K · filed 2025-02-25 |
| 2023-09-30 | $2.56M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $4.67M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $6.50M 10-Q · filed 2023-05-04 |
| 2022-09-30 | $12.09M 10-Q · filed 2022-11-03 |